These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 21802503)
1. From cancer metabolism to new biomarkers and drug targets. Chiaradonna F; Moresco RM; Airoldi C; Gaglio D; Palorini R; Nicotra F; Messa C; Alberghina L Biotechnol Adv; 2012; 30(1):30-51. PubMed ID: 21802503 [TBL] [Abstract][Full Text] [Related]
2. MR evaluation of response to targeted treatment in cancer cells. Podo F; Canevari S; Canese R; Pisanu ME; Ricci A; Iorio E NMR Biomed; 2011 Jul; 24(6):648-72. PubMed ID: 21387442 [TBL] [Abstract][Full Text] [Related]
3. Drug discovery strategies in the field of tumor energy metabolism: Limitations by metabolic flexibility and metabolic resistance to chemotherapy. Amoedo ND; Obre E; Rossignol R Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):674-685. PubMed ID: 28213330 [TBL] [Abstract][Full Text] [Related]
4. The opportunities and challenges of personalized genome-based molecular therapies for cancer: targets, technologies, and molecular chaperones. Workman P Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S45-56. PubMed ID: 12819933 [TBL] [Abstract][Full Text] [Related]
5. Predicting drug targets and biomarkers of cancer via genome-scale metabolic modeling. Jerby L; Ruppin E Clin Cancer Res; 2012 Oct; 18(20):5572-84. PubMed ID: 23071359 [TBL] [Abstract][Full Text] [Related]
6. Regulation of glucose metabolism by 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatases in cancer. Yalcin A; Telang S; Clem B; Chesney J Exp Mol Pathol; 2009 Jun; 86(3):174-9. PubMed ID: 19454274 [TBL] [Abstract][Full Text] [Related]
9. Opportunities in discovery and delivery of anticancer drugs targeting mitochondria and cancer cell metabolism. Pathania D; Millard M; Neamati N Adv Drug Deliv Rev; 2009 Nov; 61(14):1250-75. PubMed ID: 19716393 [TBL] [Abstract][Full Text] [Related]
10. Taking advantage of tumor cell adaptations to hypoxia for developing new tumor markers and treatment strategies. Ebbesen P; Pettersen EO; Gorr TA; Jobst G; Williams K; Kieninger J; Wenger RH; Pastorekova S; Dubois L; Lambin P; Wouters BG; Van Den Beucken T; Supuran CT; Poellinger L; Ratcliffe P; Kanopka A; Görlach A; Gasmann M; Harris AL; Maxwell P; Scozzafava A J Enzyme Inhib Med Chem; 2009 Apr; 24 Suppl 1():1-39. PubMed ID: 19330638 [TBL] [Abstract][Full Text] [Related]
11. Hypoxia-induced metabolic shifts in cancer cells: moving beyond the Warburg effect. Weljie AM; Jirik FR Int J Biochem Cell Biol; 2011 Jul; 43(7):981-9. PubMed ID: 20797448 [TBL] [Abstract][Full Text] [Related]
12. Mass spectrometry-based clinical proteomics: head-and-neck cancer biomarkers and drug-targets discovery. Matta A; Ralhan R; DeSouza LV; Siu KW Mass Spectrom Rev; 2010; 29(6):945-61. PubMed ID: 20945361 [TBL] [Abstract][Full Text] [Related]
13. Targeting glucose metabolism: an emerging concept for anticancer therapy. Madhok BM; Yeluri S; Perry SL; Hughes TA; Jayne DG Am J Clin Oncol; 2011 Dec; 34(6):628-35. PubMed ID: 20805739 [TBL] [Abstract][Full Text] [Related]
14. Cancer stem cell targeted agents: therapeutic approaches and consequences. Chumsri S; Burger AM Curr Opin Mol Ther; 2008 Aug; 10(4):323-33. PubMed ID: 18683096 [TBL] [Abstract][Full Text] [Related]
15. Pharmaco-metabolomics: an emerging "omics" tool for the personalization of anticancer treatments and identification of new valuable therapeutic targets. Corona G; Rizzolio F; Giordano A; Toffoli G J Cell Physiol; 2012 Jul; 227(7):2827-31. PubMed ID: 22105661 [TBL] [Abstract][Full Text] [Related]
16. Cancer Drug Development: New Targets for Cancer Treatment. Curt GA Oncologist; 1996; 1(3):II-III. PubMed ID: 10387987 [TBL] [Abstract][Full Text] [Related]
18. Interpretation of treatment results with biological agents: is there a need for a new methodology? Begent RH J BUON; 2007 Sep; 12 Suppl 1():S53-8. PubMed ID: 17935278 [TBL] [Abstract][Full Text] [Related]
19. Biomarker assay translation from discovery to clinical studies in cancer drug development: quantification of emerging protein biomarkers. Lee JW; Figeys D; Vasilescu J Adv Cancer Res; 2007; 96():269-98. PubMed ID: 17161683 [TBL] [Abstract][Full Text] [Related]